Aminoglycosides versus bacteria - A description of the action, resistance mechanism, and nosocomial battleground

Journal of Biomedical Science

Volumn 15, Issue 1, 2008, Pages 5-14

  Shakil, Shazi ^a   Khan, Rosina ^a   Zarrilli, Raffaele ^b   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Aminoglycoside resistance; Aminoglycoside modifying enzymes; Drug resistance; Hospital infection; Nosocomial infection; Resistance mechanism; Spread of resistance

Indexed keywords

2 DEOXYSTREPTAMINE; AMIKACIN; AMINOCYCLITOL; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; APRAMYCIN; FRAMYCETIN; GENTAMICIN; HABEKACIN; HYGROMYCIN B; KANAMYCIN A; KANAMYCIN B; NEOMYCIN; NETILMICIN; PAROMOMYCIN; RNA 16S; SISOMICIN; SPECTINOMYCIN; STREPTIDINE; STREPTOMYCIN; TOBRAMYCIN;

ACETYLATION; ADENYLATION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIAL CELL; BACTERIUM; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CHEMICAL STRUCTURE; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG MECHANISM; DRUG STRUCTURE; EPIDEMIC; GENE MUTATION; HOSPITAL INFECTION; HUMAN; MEMBRANE TRANSPORT; METHYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; PUBLIC HEALTH; REVIEW; RIBOSOME SUBUNIT; THREE DIMENSIONAL IMAGING;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; BASE SEQUENCE; BINDING SITES; CROSS INFECTION; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; NUCLEIC ACID CONFORMATION; RIBOSOMES; RNA, BACTERIAL;

BACTERIA (MICROORGANISMS);

EID: 36749103255     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9194-y     Document Type: Review

References (66)

1. Akram M., Shahid M. and Khan A.U., Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann. Clin. Microbiol. Antimicrob. 6: 4, 2007
2. Khan A.U., Musharraf A. (2004) Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection. Med. Sci. Monit. 10:CR598-602
3. Marra A.R., Wey S.B., Castelo A. et al., Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect. Dis. 6: 24 doi: 10.1186/1471-2334-6-24, 2006
4. Liou G.F., Yoshizawa S., Courvalin P., Galimand M. (2006) Aminoglycosides resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens. J. Mol. Biol. 359:358-364
5. Kotra L.P., Haddad J., Mobashery S. (2000) Aminoglycoside: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44:3249-3256
6. Magnet S., Blanchard J.S. (2005) Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105:477-497
7. Nikaido H. (2003) Molecular basis of bacterial outer membrane permeability revisited. Microbiol. Mol. Biol. Rev. 67:593-656
8. Taber H.W., Mueller J.P., Miller P.F., Arrow A.S. (1987) Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439-457
9. Magnet S., Courvalin P., Lambert T. (2001) Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45:3375-3380
10. Moore R.A., DeShazer D., Reckseidler S., Weissman A., Woods D.E. (1999) Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43:465-470
11. Magnet S., Smith T.A., Zheng R., Nordmann P., Blanchard J.S. (2003) Aminoglycoside resistance resulting from tight drug binding to an altered aminoglycoside acetyltransferase. Antimicrob. Agents Chemother. 47:1577-1583
12. Menard R., Molinas C., Arthur M., Duval J., Courvalin P., Leclercq R. (1993) Overproduction of 3′-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coli. Antimicrob. Agents. Chemother. 37:78-83
13. Musser J.M. (1995) Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin. Microbiol. Rev. 8:496-514
14. Skeggs P.A., Thompson J., Cundliffe E. (1985) Methylation of 16 S ribosomal RNA and resistance to aminoglycoside antibiotics in clones of Streptomyces lividans carrying DNA from Streptomyces tenjimariensis. Mol. Gen. Genet. 200:415-421
15. Cundliffe E. (1989) How antibiotic-producing organisms avoid suicide. Annu. Rev. Microbiol. 43:207-233
16. Thompson J., Skeggs P.A., Cundliffe E. (1985) Methylation of 16 S ribosomal RNA and resistance to the aminoglycoside antibiotics gentamicin and kanamycin determined by DNA from the gentamicin producer, Micromonospora purpurea. Mol. Gen. Genet. 201:168-173
17. Gilbert D.N. (1985) Aminoglycosides. In: Mandell GL, Bennett JE, Dolin R, (eds). Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone, New York, NY, pp. 279-306
18. Mingeot-Leclercq M.P., Glupczynski Y., Tulkens P.M. (1999) Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737
19. Sakon J., Liao H.H., Kanikula A.M., Benning M.M., Rayment I., Holden H.M. (1993) Molecular structure of kanamycin nucleotidyl transferase determined to 3 Å resolution. Biochemistry 32:11977-11984
20. Wybenga-Groot L.E., Draker K., Wright G.D., Berghuis A.M. (1999) Crystal structure of an aminoglycoside 6'-N-acetyltransferase: defining the GCN5-related N-acetyltransferase superfamily fold. Struct. Fold. Des. 7:497-507
21. Burk D.L., Hon W.C., Leung A.K., Berghuis A.M. (2001) Structural analyses of nucleotide binding to an aminoglycoside phosphotransferase. Biochemistry 40:8756-8764
22. Spelman D.W., McDonald M., Spice W.J. (1989) Aminoglycoside antibiotic agents: a review. Therapeutics 151:346-349
23. Hancock R.E., Farmer S.W., Li Z.S., Poole K. (1991) Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of E. coli. Antimicrob. Agents Chemother. 35:1309-1314
24. Bryan L.E., Kwan S. (1983) Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23:835-845
25. Ban N., Nissen P., Hansen J., Moore P.B., Steitz T.A. (2000) The complete atomic structure of the large ribosomal subunit at 2.4 Å resolution. Science 289:905-920
26. Fourmy D., Yoshizawa S., Puglisi J.D. (1998) Paromomycin binding induces a local conformational change in the A-site of 16 S rRNA. J. Mol. Biol. 277:333-345
27. Noller H.F. (1991) Ribosomal RNA and translation. Annu. Rev. Biochem. 60:191-227
28. Fourmy D., Recht M.I., Blanchard S.C., Puglisi J.D. (1996) Structure of the A-site of E. coli. 16 S rRNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371
29. Recht M.I., Fourmy D., Blanchard S.C., Dahlquist K.D., Puglisi J.D. (1996) RNA sequence determinants for aminoglycoside binding to an A-site rRNA model oligonucleotide. J. Mol. Biol. 262:421-436
30. Cate J.H., Yusupov M.M., Yusupova G.Z., Earnest T.E., Noller H.F. (1999) X-ray crystal structure of 70S ribosome functional complexes. Science 285:2095-2104
31. Jiang L., Patel D.J. (1998) Solution structure of the tobramycin-RNA aptamer complex. Nat. Struct. Biol. 5:769-774
32. Xi H., Arya D.P. (2005) Recognition of triple helical nucleic acids by aminoglycosides. Curr. Med. Chem. Anticancer Agents 5:327-338
33. Hermann T., Westhoff E. (1998) Saccharide-RNA recognition. Biopolymers 48:155-165
34. Recht M.I., Douthwaite S., Puglisi J.D. (1999) Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J 18:3133-3138
35. Michael K., Wang H., Tor Y. (1999) Enhanced RNA binding of dimerized aminoglycosides. Bioorg. Med. Chem. 7:1361-1371
36. Welch K.T., Virga K.G., Whittemore N.A., Ozen C., Wright E., Brown C.L., Lee R.E., Serpersu E.H. (2005) Discovery of non-carbohydrate inhibitors of aminoglycoside-modifying enzymes. Bioorg. Med. Chem. 13:6252-6363
37. Cho J., Hamasaki K., Rando R.R. (1998) The binding site of a specific aminoglycoside binding RNA molecule. Biochemistry 37:4985-4992
38. Pilch D.S., Kaul M., Barbieri C.M. (2005) Defining the basis for the specificity of aminoglycoside-rRNA recognition: a comparative study of drug binding to the A sites of Escherichia coli and human rRNA. J. Mol. Biol. 346:119-134
39. Hayashi S.F., Norcia L.J., Seibel S.B., Silvia A.M. (1997) Structure activity relationships of hygromycin A and its analogs: protein synthesis inhibition activity in a cell free system. J. Antibiot. (Tokyo) 50:514-521
40. Hotta K., Zhu C.B., Ogata T., Sunada A., Ishikawa J., Mizuno S., Kondo S. (1996) Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product. J. Antibiot. (Tokyo) 49:458-464
41. Shaw K.J., Rather P.N., Hare R.S., Miller G.H. (1993) Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol. Rev. 57:138-163
42. Llano-Sotelo B., Azucena E.F., Kotra L.P., Mobashery S., Chow C.S. (2002) Aminoglycosides modified by resistance enzymes display diminished binding to the bacterial ribosomal aminoacyl-tRNA site. Chem. Biol. 9:455-463
43. Mingeot-Leclercq M.-P., Glupczynski Y., Tulkens P.M. (1999) Aminoglycosides: activity and resistance. Antimicrob. Agents Chemother. 43:727-737
44. Vakulenko S.B., Donabedian S.M., Voskresenskiy A.M., Zervos M.J., Lerner S.A., Chow J.W. (2003) Multiplex PCR for detection of aminoglycoside resistance genes in enterococci. Antimicrob. Agents Chemother. 47(4):1423-1426
45. Zarrilli R., Tripodi M., Di Popolo A. et al. (2005) Molecular epidemiology of high-level amino glycoside-resistant enterococci isolated from patients in a university hospital in southern Italy. J. Antimicrob. Chemother. 56:827-835
46. Ahmed A.M., Shimamoto T. (2004) A plasmid-encoded class 1 integron carrying sat, a putative phosphoserine phosphatase gene and aadA2 from enterotoxigenic Escherichia coli O159 isolated in Japan. FEMS Microbiol. Lett. 235:243-248
47. Rather P.N., Munayyer H., Mann P.A., Hare R.S., Miller G.H., Shaw K.J. (1992) Genetic analysis of bacterial acetyltransferases: identification of amino acids determining the specificities of the aminoglycoside 69- Nacetyltransferase-Ib and IIa proteins. J. Bacteriol. 174:3196-3203
48. Wu H.Y., Miller G.H., Blanco M.G, Hare RS, Shaw K.J. (1997) Cloning and characterization of an aminoglycoside 69-N-acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile. Antimicrob. Agents Chemother. 41:2439-2447
49. Aires J.R., Kohler T., Nikaido H., Plesiat P. (1999) Involvement of an active efflux system in the natural resistance of Pseudomonas aeruginosa to aminoglycosides. Antimicrob. Agents Chemother. 43:2624-2628
50. Masuda N., Sakagawa E., Ohya S., Gotoh N., Tsujimoto H., Nishino T. (2000) Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 44:3322-3327
51. Westbrock-Wadman S., Sherman D.R., Hickey M.J. et al. (1999) Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob. Agents Chemother. 43:2975-2983
52. Livermore D.M. (2002) Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin. Infect. Dis. 34:634-640
53. Poole K. (2005) Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51
54. Maravic G. (2004) Macrolide resistance based on the Erm-mediated rRNA methylation. Curr. Drug Targets Infect. Disord. 4:193-202
55. Doi Y., Yokoyama K., Yamane K. et al. (2004) Plasmid-mediated 16S rRNA methylase in Serratia marcescens conferring highlevel resistance to aminoglycosides. Antimicrob. Agents Chemother. 48:491-496
56. Galimand M., Sabtcheva S., Courvalin P., Lambert T. (2005) Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob. Agents Chemother. 49:2949-2953
57. Chow J.W. (2000) Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 31:586-599
58. Lester C.H., Frimodt-Moller N., Hammerum A.M. (2004) Conjugal transfer of aminoglycoside and macrolide resistance between Enterococcus faecium isolates in the intestine of streptomycin-treated mice. FEMS Microbiol. Lett. 235:385-389
59. Tomita H., Pierson C., Lim S.K., Clewell D.B., Ike Y. (2002) Possible connection between a widely disseminated conjugative gentamicin resistance (pMG1-like) plasmid and the emergence of vancomycin resistance in Enterococcus faecium. J. Clin. Microbiol. 40:3326-3333
60. Udo E.E., Al-Sweih N., John P., Jacob L.E., Mohanakrishnan S. (2004) Characterization of high-level aminoglycoside-resistant enterococci in Kuwait hospitals. Microb. Drug Resist. 10:139-145
61. Campo R.D., Ruiz-Garbajosa P., Sanchez-Moreno M.P. et al. (2003) Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes. Microb. Drug Resist. 9:47-60
62. Donabedian S.M., Thal L.A., Hershberger E. et al. (2003) Molecular characterization of gentamicin-resistant enterococci in the United States: evidence of spread from animals to humans through food. J. Clin. Microbiol. 41:1109-1113
63. Rybak L.P., Whitworth C.A. (2005) Ototoxicity: therapeutic opportunities. Drug Discov. Today 10:1313-1321
64. Rougier F., Claude D., Maurin M., Maire P. (2004) Aminoglycoside nephrotoxicity. Curr. Drug Targets 4:153-162
65. Peloquin C.A., Berning S.E., Nitta A.T., Simone P.M., Goble M., Huitt G.A., Iseman M.D., Cook J.L., Curran-Everett D. (2004) Aminoglycoside toxicity: daily versus thrice weekly dosing for treatment of mycobacterial diseases. Clin. Infect. Dis. 38:1538-1544
66. Magnet S., Blanchard J.S. (2005) Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105:477-497